1OKURA T, NAKATA Y, YAMABUKI K, et al. Regional body composition changes exhibit opposing effects on eoronary heart disease risk factors[J]. Arterioscler Thromb Vase Biol,2004 ,24:923-929.
2IACOBELLIS G, RIBAUDO M C, ZAPPATERRENO A, et al. relation between epicardial adipose tissue and left ventrieular mass[J]. Am J Cardiol, 2004 ,94:1084-1087.
3HENRICHOT E, JUGE AUBRY C E, PERNIN A, et al. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? [J]. Arterioscler Thromb Vasc Biol, 2005 , 25: 2594-2599.
4PILZ S, SCHARNAGL H, TIRAN B, et al. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease[J]. J Clin Endocrinol Metab,2006,91:2542 2547.
5SONG M J, KIM K H, YOON J M, et al. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes[J]. Biochem Biophys Res Commun, 2006,346 : 739 -745.
6Emanuela B,Minarini A,Tumiatti V. Synthetic polyamines as potential amine oxidase inhibitors:a preliminary study[J].Amino Acids,2012.913-928.
7Wilson SR,Sabatine MS,Wiviott SD. Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome:observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22)[J].American Heart Journal,2011.1147-1155.
8Koh KK,Park SM,Quon MJ. Leptin and cardiovascular disease:response to therapeutic interventions[J].Circulation,2008.3238-3249.
9Reilly MP,Lehrke M,Wolfe ML. Resistin is an inflammatory marker of atherosclerosis in humans[J].Circulation,2005.932-939.
10Fukuhara A,Matsuda M,Nishizawa M. Visfatin:a protein secreted by visceral fat that mimics the effects of insulin[J].Science,2005,(5708):426-430.doi:10.1126/science.1097243.
